# Dyne Therapeutics, Inc.: Form 8-K, filed Mar 2, 2023

- Company: [Dyne Therapeutics, Inc.](/companies/dyn.md) (CIK 1818794)
- Form: 8-K
- Filed: 2023-03-02
- Accepted by EDGAR: Mar 2, 2023, 07:35 ET
- Period: 2023-03-02
- Accession: 0000950170-23-005714
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818794/000095017023005714/dyn-20230302.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818794/000095017023005714/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818794/000095017023005714/dyn-20230302.htm

Filed Mar 2, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-005714. Last ingested by Listed: Nov 5, 2026, 12:06 ET. No prices; not investment advice.